EDGAR Filing Documents for 0001387131-17-004691

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001387131-17-004691

Filing Date

2017-09-15

Accepted

2017-09-15 17:09:38

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	REGISTRATION STATEMENT	ohr-s3_091117.htm	S-3	388238
2	FORM OF SERIES A WARRANT	ex4-9.htm	EX-4.9	383525
3	FORM OF SERIES B WARRANT	ex4-11.htm	EX-4.11	392271
4	OPINION OF TROUTMAN SANDERS LLP	ex5-1.htm	EX-5.1	35216
5	COMPUTATION OF RATIO OF EARNINGS	ex12-1.htm	EX-12.1	28836
6	CONSENT OF MALONEBAILEY, LLP	ex23-1.htm	EX-23.1	4023
7	GRAPHIC	ohrs3091117001.jpg	GRAPHIC	15151
8	GRAPHIC	image_001.gif	GRAPHIC	3497
9	GRAPHIC	image_001.jpg	GRAPHIC	4525
	Complete submission text file	0001387131-17-004691.txt		1265615

Mailing Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022

Business Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022 (212) 682-8452

Ohr Pharmaceutical Inc (Filer) CIK: 0001173281 (see all company filings)